Consultant in endocrinology and diabetes Professor Vinod Patel discusses current recommended pharmacological treatment ...

Conclusion: The results of this meta-analysis seem to support that periodontal treatment with aPDT + Doxy possesses the best efficacy in lowering HbA1c% of non-smoking CP without severe T2DM ...

Drinking ketones improves heart health, a new small-scale study from the University of Portsmouth has found. Patients with ...

Glucose homeostasis regulation is the core of T2DM treatment, this review highlights a new signaling molecule, RNAkine, which has emerged as a critical regulator of glucose homeostasis.

Now, the US Food and Drug Administration (FDA) has issued a final guidance for industry on how to use clinical trials to show that a new T2DM treatment is not associated with an unacceptable ...

The Indian phenotype of T2DM patients is associated with clustering of cardiovascular risk factors, increased insulin ...

However, limited research has been conducted to assess the concentrations of serum SCFAs, and evidence exploring associations of different blood SCFAs with the risk of T2DM is scarce. Recently ...

People with T2DM with impaired kidney function are at a very high risk of CVD, and as such, it is imperative to implement treatment strategies that safeguard kidney function. 7 Effective ...

Although gut microbiota and lipid metabolites have been suggested to be closely associated with type 2 diabetes mellitus (T2DM), the interactions between gut microbiota, ...

Raymond James analyst Steven Seedhouse raised the firm’s price target on Viking Therapeutics (VKTX) to $125 from $122 and keeps a Strong Buy ...